One potential mechanism could be increased prevalence of NAION risk factors in patients starting GLP-1RA or that sudden and rapid decline in blood glucose could increase the risk of diabetic papillopathy or worsened DR
My memory and focus are sharper, and my doctor even reduced my blood pressure meds after seeing improvements
Ordering is always super simple though shipping took an extra day this time
Currently, there are three FDA-approved oral GLP-1s on the market in the US: Rybelsus, which is approved for type 2 diabetes, the Wegovy pill, which is approved for weight loss, and Foundayo, which is also approved for weight loss
This limited study can't answer every safety question, especially for newborns or exclusively breastfed babies
doi: 10.1159/000083323 166 BacchettaJVillardFVialTDubourgLBouvierRKassaiBet al